Totaro, Angelo
 Distribuzione geografica
Continente #
EU - Europa 5.873
NA - Nord America 3.390
AS - Asia 2.441
SA - Sud America 495
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
AN - Antartide 1
Totale 12.281
Nazione #
US - Stati Uniti d'America 3.265
IT - Italia 2.587
DE - Germania 1.374
SG - Singapore 1.141
CN - Cina 648
SE - Svezia 512
BR - Brasile 392
FR - Francia 330
UA - Ucraina 303
GB - Regno Unito 207
IN - India 172
IE - Irlanda 120
VN - Vietnam 106
ID - Indonesia 87
CA - Canada 79
NL - Olanda 79
RU - Federazione Russa 79
FI - Finlandia 74
HK - Hong Kong 53
PL - Polonia 53
AR - Argentina 44
TR - Turchia 43
BD - Bangladesh 30
CH - Svizzera 30
MX - Messico 30
BE - Belgio 27
ES - Italia 24
IQ - Iraq 19
AT - Austria 17
JP - Giappone 17
ZA - Sudafrica 17
CI - Costa d'Avorio 15
KR - Corea 15
PK - Pakistan 15
CO - Colombia 14
EC - Ecuador 13
AZ - Azerbaigian 11
LT - Lituania 11
AE - Emirati Arabi Uniti 10
IR - Iran 9
JO - Giordania 9
PE - Perù 9
EU - Europa 8
VE - Venezuela 8
EG - Egitto 7
RO - Romania 7
CL - Cile 6
MY - Malesia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AU - Australia 5
KE - Kenya 5
LK - Sri Lanka 5
MA - Marocco 5
PT - Portogallo 5
CZ - Repubblica Ceca 4
HU - Ungheria 4
KG - Kirghizistan 4
PH - Filippine 4
PY - Paraguay 4
UY - Uruguay 4
DK - Danimarca 3
GR - Grecia 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
SN - Senegal 3
TN - Tunisia 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
CM - Camerun 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
Totale 12.264
Città #
Chandler 548
Singapore 532
Rome 368
Ashburn 326
Milan 251
Jacksonville 164
Los Angeles 134
Beijing 133
Ann Arbor 116
Dublin 116
San Mateo 106
New York 91
Nürnberg 87
Nanjing 83
Jakarta 79
Dearborn 71
Munich 69
Florence 67
Hefei 63
Wilmington 63
Woodbridge 61
Nanchang 56
Boston 51
Frankfurt am Main 50
Hong Kong 50
São Paulo 50
Bremen 48
The Dalles 47
Houston 46
Naples 44
Bologna 41
Ho Chi Minh City 41
Moscow 41
Lawrence 39
Dallas 38
Bari 37
Ottawa 37
Verona 32
Chicago 31
Redwood City 30
Palermo 26
Fairfield 25
Hyderabad 25
Seattle 25
Princeton 24
Redmond 24
Turin 24
Hanoi 23
Kraków 23
Marseille 23
Catania 22
Izmir 20
Brussels 19
Kent 19
Mountain View 19
Buffalo 18
London 18
Stockholm 18
Helsinki 17
Cattolica 16
Abidjan 15
Genoa 15
New Delhi 15
Paris 15
Santa Clara 15
University Park 15
Belo Horizonte 14
Brooklyn 14
Denver 14
Jiaxing 14
Kunming 14
Montreal 14
Seoul 14
Tokyo 14
Toronto 14
Warsaw 14
Augusta 13
Bexley 13
Cagliari 13
Düsseldorf 13
Hebei 13
Shenyang 13
Brescia 12
Lauterbourg 12
Miami 12
Nuremberg 12
Orem 12
Atlanta 11
Baku 11
Johannesburg 11
Tianjin 11
Amsterdam 10
Falls Church 10
Padova 10
Phoenix 10
Sesto Fiorentino 10
Treviso 10
Vienna 10
Changsha 9
Curitiba 9
Totale 5.265
Nome #
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.184
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 905
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 854
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 333
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 312
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 304
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 298
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 233
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 230
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 201
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 176
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 171
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 171
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 154
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 152
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 149
Imaging in prostate cancer diagnosis: present role and future perspectives 148
[Overactive bladder syndrome: the social and economic perspective] 148
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 148
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 147
Brachytherapy in men with prostate cancer: update on indications and outcomes 145
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 142
Microbiological follow-up of nosocomial infections in a single urological center 142
Advanced bladder cancer: New agents and new approaches. A review 141
Imaging of renal cell carcinoma: state of the art and recent advances 141
Imaging in prostate cancer staging: present role e future perspectives 141
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 138
Advanced bladder cancer: New agents and new approaches. A review 136
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 133
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 133
Imaging in prostate cancer staging: present role and future perspectives 127
Inhibition of prostate efferent neurotransmission by amikacin 126
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 125
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 122
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 122
Circumcision: history, religion and law 121
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 120
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 117
Imaging of renal cell carcinoma: state of the art and recent advances 114
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 114
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 111
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 109
Imaging in prostate cancer diagnosis: present role and future perspectives 108
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 108
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 108
Zinner syndrome: Two cases and review of the literature 108
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 107
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 98
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 97
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 96
Imaging of renal cell carcinoma: state of the art and recent advances. 95
Management of Iatrogenic Bladder Injury due to Vascular Surgery: Case Report and Literature Review 94
InTrathecal mORphine, traNsversus Abdominis Plane Block, and tramaDOl Infusion for Catheter-Related Bladder Discomfort in Patients Undergoing Robot-Assisted Laparoscopic Prostatectomy (TORNADO): A Pilot Prospective Controlled Study 94
18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study 93
Depiction of periprostatic nerve fibers by means of 1.5 T diffusion tensor imaging 90
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 87
[Doping and urologic tumors] 87
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 86
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 86
ECG-gated CT angiography of the thoracic aorta: the importance of evaluating the coronary arteries 79
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 77
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 77
[Continuing evolution of statistical tests in medical research] 77
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 76
What can the metaverse do for urology? 75
[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives] 74
[Prostatitis syndromes and sporting activities] 72
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 70
Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional Outcomes 69
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 68
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 65
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 64
Relationship between Middle Cerebral Artery Pulsatility Index and Delayed Neurocognitive Recovery in Patients undergoing Robot-Assisted Laparoscopic Prostatectomy 61
Circumcision: history, religion and law 59
Bladder tumor markers: A review of the literature 59
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 57
In vitro effect of amikacin on rat and human detrusor muscle contraction 55
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 51
Markers for Urological Malignancies 47
Imaging in bladder cancer: Present role and future perspectives 43
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 39
Metastasis to the renal hilum from malignant melanoma of the anterior trunk: An unusual finding 37
Social, economic, and health utility considerations in the treatment of overactive bladder 36
Recovery from deep neuromuscular blockade using different sugammadex doses in elderly patients undergoing laparoscopic robot-assisted prostatectomy 34
Totale 12.401
Categoria #
all - tutte 42.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.309


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 41 89 37 88 43 108 42
2021/2022852 83 51 43 84 64 37 30 94 66 66 105 129
2022/20231.761 208 202 156 271 114 203 83 147 186 62 73 56
2023/20241.617 96 225 106 149 110 124 112 155 83 138 119 200
2024/20252.175 111 78 187 108 189 86 127 117 267 228 374 303
2025/20262.285 570 119 265 421 765 145 0 0 0 0 0 0
Totale 12.401